8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with s 15261 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, S; Boulanger, M; Della Zuana, O; Duhault, J; Lacour, F; Wierzbicki, M | 1 |
1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and s 15261
| Article | Year |
|---|---|
General pharmacology of S 15261, a new concept for treatment of diabetes.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Monoamines; Blood Glucose; Blood Pressure; Brain Chemistry; Feeding Behavior; Female; Fluorenes; Guinea Pigs; Insulin Resistance; Male; Mice; Pain Measurement; Radioligand Assay; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cell Surface; Serotonin Receptor Agonists | 1998 |